GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for trans-aconitate 2-methyltransferase (B3QFV9)

Analyse AlphaFold monomer V2.0 prediction for trans-aconitate 2-methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B3QFV9
Type
protein
Length
256 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x79a905d858Ce72991FD6E7a9C6498620f42E146D
Molecule
Trans-aconitate 2-methyltransferase
UniProt
B3QFV9
Pockets
1 · best druggability 0.75

Structure

1 distinct chain · 43% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATrans-aconitate 2-methyltransferaseprotein25643% helix, 21% strandB3QFV9

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15080.750.8353empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.